{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:34:22Z","timestamp":1788910462689,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bioorg.2021.105173","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T01:16:11Z","timestamp":1626311771000},"page":"105173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Synthesis, antitubercular, antimicrobial activities and molecular docking study of quinoline bearing dihydropyrimidines"],"prefix":"10.1016","volume":"115","author":[{"given":"Nisheeth C.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam M.","family":"Kotadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krunalsinh A.","family":"Jadeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alimamad H.","family":"Malani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijjulatha","family":"Manga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamalapakula","family":"Vani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105173_b0005","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(13)62078-4","article-title":"WHO's, global report on tuberculosis: successes, threats, and opportunities","volume":"382","author":"Zumla","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2021.105173_b0010","unstructured":"Global Tuberculosis Report 2020, 2020. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/en\/."},{"key":"10.1016\/j.bioorg.2021.105173_b0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(13)70030-6","article-title":"Drug-resistant tuberculosis: time for visionary political leadership","volume":"13","author":"Abubakar","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2021.105173_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-012-0278-6","article-title":"Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines","volume":"202","author":"Prabowo","year":"2013","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.bioorg.2021.105173_b0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bioorg.2018.07.028","article-title":"Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents","volume":"80","author":"Atta","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0030","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.ejmech.2009.06.031","article-title":"Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety","volume":"44","author":"Eswaran","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.trstmh.2004.01.013","article-title":"Treatment of acute vivax malaria with tafenoquine","volume":"99","author":"Nasveld","year":"2005","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bioorg.2021.105173_b0040","unstructured":"W. A. Denny, W. R. Wilson, D. C. Ware, G. J. Atwell, J. B. Milbank, R. J .Stevenson, US Patent 7064117, 2006. https:\/\/patents.google.com\/patent\/US7064117B2\/en\/."},{"key":"10.1016\/j.bioorg.2021.105173_b0045","first-page":"209","article-title":"A double blind study of antrafenine, naproxen and placebo in osteoarthrosis","volume":"6","author":"Leatham","year":"1983","journal-title":"Eur. J. Rheumatol. Inflamm."},{"key":"10.1016\/j.bioorg.2021.105173_b0050","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1248\/bpb.27.1683","article-title":"Synthesis, Anticonvulsant and Antihypertensive Activities of 8-Substituted Quinoline Derivatives","volume":"27","author":"Muruganantham","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2021.105173_b0055","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/jm00040a003","article-title":"A New Series of PDGF Receptor Tyrosine Kinase Inhibitors: 3-Substituted Quinoline Derivatives","volume":"37","author":"Maguire","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0060","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm00109a031","article-title":"Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents","volume":"34","author":"Strekowski","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0065","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","article-title":"Synthesis and in vitro antitubercular activity of a series of quinoline derivatives","volume":"17","author":"de Souza","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103626","article-title":"Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides","volume":"96","author":"Marvadi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0075","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/jm900003c","article-title":"Structure\u2212Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating Mycobacterium tuberculosis","volume":"52","author":"Lilienkampf","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0080","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.01204-07","article-title":"Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis","volume":"52","author":"Rustomjee","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105173_b0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cmdc.200600010","article-title":"Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents","volume":"1","author":"Sarva","year":"2006","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0090","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/AAC.48.9.3556-3558.2004","article-title":"SRI-286, a Thiosemicarbazole, in Combination with Mefloquine and Moxifloxacin for Treatment of Murine Mycobacterium avium Complex Disease","volume":"48","author":"Bermudez","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105173_b0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/rccm.201308-1446ED","article-title":"Fluoroquinolones in the Treatment of Tuberculosis: Which Is Best?","volume":"188","author":"Schluger","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bioorg.2021.105173_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbdv.200490173","article-title":"Pyrimidine as Constituent of Natural Biologically Active Compounds","volume":"2","author":"Lagoja","year":"2005","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2021.105173_b0105","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0968-0896(98)00064-9","article-title":"Novel antiallergic agents. Part I: Synthesis and pharmacology of pyrimidine amide derivatives","volume":"6","author":"Ban","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1021\/jm00368a013","article-title":"Improved and large-scale synthesis of certain glycosyl cyanides. Synthesis of 2,5-anhydro-5-thio-d-allononitrile","volume":"27","author":"Wright","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bioorg.2019.01.017","article-title":"EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel antiinflammatory EGFR inhibitor","volume":"86","author":"Elkamhawy","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0120","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0968-0896(99)00050-4","article-title":"Potent 1, 3-disubstituted-9H-pyrido [3, 4-b] indoles as new lead compounds in antifilarial chemotherapy","volume":"7","author":"Srivastava","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0125","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1128\/AAC.46.11.3362-3369.2002","article-title":"Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase","volume":"46","author":"Gerum","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105173_b0130","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1016\/j.bmc.2007.04.011","article-title":"Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis","volume":"15","author":"El-Hamamsy","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejmech.2013.06.029","article-title":"Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1, 3, 4-oxadiazoles","volume":"67","author":"Desai","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0140","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.bmcl.2013.02.077","article-title":"Synthesis of pyrazole encompassing 2-pyridone derivatives as antibacterial agents","volume":"23","author":"Desai","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105173_b0145","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1016\/j.bmcl.2012.09.039","article-title":"Synthesis and characterization of some new quinoline based derivatives endowed with broad spectrum antimicrobial potency","volume":"22","author":"Desai","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105173_b0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","article-title":"An overview of molecular hybrids in drug discovery","volume":"11","author":"B\u00e9rub\u00e9","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.105173_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsps.2011.04.002","article-title":"Synthesis, characterization and biological evaluation of dihydropyrimidine derivatives","volume":"20","author":"Adhikari","year":"2012","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2021.105173_b0160","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.4067\/s0717-97072018000203974","article-title":"Facile ecofriendly one pot synthesis of heterocyclic priviledged medicinal scaffolds via biginelli reaction using retrievable nickel nanoparticles as catalyst","volume":"63","author":"Paul","year":"2018","journal-title":"J. Chil. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105173_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/j.1875-9114.1988.tb04058.x","article-title":"Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions","volume":"8","author":"LeBel","year":"1988","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bioorg.2021.105173_b0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIa Topoisomerase Inhibition by a New Class of Antibacterial Agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.105173_b0175","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05467.x","article-title":"Mechanisms of action of isoniazid","volume":"62","author":"Timmins","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2021.105173_b0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/febs.13102","article-title":"The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942","volume":"282","author":"Kamachi","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.bioorg.2021.105173_b0185","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/nar\/gkg245","article-title":"The crystal structure of the complex between a disaccharide anthracycline and the DNA hexamer d(CGATCG) reveals two different binding sites involving two DNA duplexes","volume":"31","author":"Temperini","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2021.105173_b0190","unstructured":"Glide (2011) version 5.6, Schrodinger, LLC, New York, U.S.A. https:\/\/www.schrodinger.com\/products\/glide."},{"key":"10.1016\/j.bioorg.2021.105173_b0195","unstructured":"QikProp (2011) version 3.4, Schrodinger, LLC, New York, U.S.A. https:\/\/www.schrodinger.com\/products\/qikprop."},{"key":"10.1016\/j.bioorg.2021.105173_b0200","first-page":"1868","article-title":"Vilsmeier-Haack reagent: A facile synthesis of 2-chloro-3-formylquinolines from N-arylacetamides and transformation into different functionalities","volume":"44B","author":"Srivastava","year":"2005","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0205","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmech.2009.09.032","article-title":"Pyrazoline bearing benzimidazoles: Search for anticancer agent","volume":"45","author":"Shaharyar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0210","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10426500701501292","article-title":"Reactions with Hydrazonoyl Halides 53:1 Synthesis and Antimicrobial Activity of Triazolino[4,3-a]pyrimidines and 5-Arylazothiazoles","volume":"182","author":"Abdelhamid","year":"2007","journal-title":"Phosphorus. Sulfur. Silicon Relat. Elem."},{"key":"10.1016\/j.bioorg.2021.105173_b0215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2174\/1381612043452721","article-title":"Recent Development and Application of Virtual Screening in Drug Discovery: An Overview","volume":"10","author":"Hou","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2021.105173_b0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van de Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.105173_b0225","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci6003515","article-title":"ADME Evaluation in Drug Discovery. 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules?","volume":"47","author":"Hou","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2021.105173_b0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"J. Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2021.105173_b0235","unstructured":"Molinspiration Cheminformatics. https:\/\/www.molinspiration.com\/cgi-bin\/properties."},{"key":"10.1016\/j.bioorg.2021.105173_b0240","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1023\/A:1020444330011","article-title":"Rate-Limited Steps of Human Oral Absorption and QSAR Studies","volume":"19","author":"Zhao","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.105173_b0245","unstructured":"Drug-likeness and molecular property prediction. https:\/\/molsoft.com\/mprop\/."},{"key":"10.1016\/j.bioorg.2021.105173_b0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4939-2450-9_17","article-title":"Microplate Alamar Blue Assay (MABA) and Low Oxygen Recovery Assay (LORA) for Mycobacterium tuberculosis","author":"Cho","year":"2015","journal-title":"Mycobacteria Protocols"},{"key":"10.1016\/j.bioorg.2021.105173_b0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ejmech.2013.03.017","article-title":"Synthesis and identification of \u03b2-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents","volume":"63","author":"Kathrotiya","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105173_b0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1051\/vetres:2000100","article-title":"Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species","volume":"31","author":"Hannan","year":"2000","journal-title":"Vet. Res."},{"key":"10.1016\/j.bioorg.2021.105173_b0265","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1080\/00397911.2015.1102286","article-title":"Studies on Antimicrobial Evaluation of Some 1-((1- (1H-Benzo[d]imidazol-2-yl)ethylidene)amino)-6- ((arylidene)amino)-2-oxo-4-phenyl-1, 2- dihydropyridine-3,5-dicarbonitriles","volume":"45","author":"Desai","year":"2015","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2021.105173_b0270","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1007\/s00044-014-1052-7","article-title":"Newer thiazolopyrimidine-based sulfonamides clubbed with benzothiazole moiety: synthesis and biological evaluation","volume":"23","author":"Patel","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2021.105173_b0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2021.105173_b0280","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2021.105173_b0285","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s11164-016-2794-2","article-title":"Synthesis and therapeutic potential of quinoline derivatives","volume":"43","author":"Narwal","year":"2017","journal-title":"Res. Chem. Intermed."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821005502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821005502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:22:29Z","timestamp":1758615749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821005502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":57,"alternative-id":["S0045206821005502"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105173","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, antitubercular, antimicrobial activities and molecular docking study of quinoline bearing dihydropyrimidines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105173"}}